Joseph M. Manak,
Esq.
PATENTS AND INTELLECTUAL PROPERTY LAW
Representations
PATENTS AND INTELLECTUAL PROPERTY LAW
Representations
PORZIO BROMBERG & NEWMAN P.C.
156 WEST 56th St. NY, NY, 10019
firm (212) 265-6888
direct (646) 348-6745
fax (212) 957-3983
jmmanak@pbnlaw.com
www.pbnlaw.com
156 WEST 56th St. NY, NY, 10019
firm (212) 265-6888
direct (646) 348-6745
fax (212) 957-3983
jmmanak@pbnlaw.com
www.pbnlaw.com
| Some of Mr. Manak's reported matters include: | |
| Litigations: | |
| Human Genome Sciences, Inc.v. Advanced Life Science Institute, Inc. Patent Interference 105,501 (RES) U.S.P.T.O. Patent interference concerning DNA encoding S100 proteins. |
|
 |
Abbot Laboratories v. Paddock/Par Pharmaceuticals Hatch Waxman patent litigation. |
| Leviton Manufacturing Co., Inc. v. Shanghai Meihao et al. Mult-district electronics patent litigation. |
|
| Novo Nordisk v. Teva Pharmaceuticals USA, Inc. Civil Action No. 02-332-SLR Patent Infringement action and district court appeal of USPTO interference. |
|
| PE Corp. and Roche Molecular Systems v. MJ Research Case No. 3-98-CV-1201 Patent infringement litigation involving polymerase chain reaction. |
|
| Leviton Manufacturing Co., Inc. v. Yatai USA LLC et al. Multidistrict action involving ground fault circuit interrupters. |
|
| University of Rochester v. Merck Patent Interference No. 104,289 (U.S.P.T.O. 2001) Patent interference related to discovery of Cox-2 gene and protein. |
|
| Merck Frosst Canada v. Monsanto Company Case No. 1:99 CV 02620 (Thomas Penfield Jackson) District Court action related to Cox-2 inhibitor VIOXX |
|
| Monsanto Corp. and G.D. Searle & Co. v. Merck Inc. Interference Nos.103,873; 103845 Large scale patent interference involving cycooxegenase II inhibitors, next generation anti-inflammatories. |
|
| Novo Nordisk A/S et al v. Eli Lilly and Company and Genentech Inc. Civ. Action No. 97-4848 (AET) (D. N.J.) Patent infringement litigation concerning recombinant DNA production of Human Growth Hormone |
|
| Eli Lilly and Company v. Novo Nordisk A/S et al. Civ. Action No. IP 97-1834 C (S.D. Indiana) Patent infringement and validity action involving Human Growth Hormone formulation patent. |
|
| Genentech Inc. v. Novo Nordisk A/S and Biotechnology General Civ. Action Nos. 95 Civ. 3474, 94 Civ. 8634, 95 Civ. 0110, 94 Civ. 1755 (S.D.N.Y.), and Intern. Trade Comm’n. Multiple patent infringement, validity and antitrust actions in Southern District of New York and International Trade Commission concerning recombinant DNA production of Insulin and Human Growth Hormone. |
|
| Emory University v. Glaxo Wellcome PLC and Biochem Pharma Inc. Civ. Action No. 1-96-CV 1868-GET (N.D.Ga.) Patent infringement and validity action involving enantiomeric compounds and chiral chemistry related to AIDs drug Epivir. |
|
| Securities and Exchange Commission v. Femminella et al. Civ. Action No. 96 Civ. 336 (S.D.N.Y.) SEC enforcement action for securities fraud relating to bond trading. |
|
| Grumman Aerospace Corporation v. TechMatics et al. 95 Civ. 966 (Platt) E.D.NY. Trade secret and unfair competition claims concerning aerospace and automotive technology. |
|
| Marion Merrell Dow Inc. et al. v. Baker Norton Pharmaceuticals, Inc. 94 Civ. 1245 (Moreno) S.D. Fla. Action concerning the antihistamine Seldane® against generic drug manufacturers under Hatch-Waxman Act. |
|
| Alpex Computer Corp. v. Nintendo Company Ltd. et al. 86 Civ. 1749 (KMW) S.D.N.Y. Assisted Honorable Kimba M. Wood, U.S.D.J., and Special Master Thomas L. Creel in trial on infringement of Alpex patent relating to computer video games. |
|
| Hoechst Celanese Corporation v. Allied-Signal Inc. Civil Action No. 3:92CV66-MU, W.D.N.C. Patent and antitrust action relating to industrial fibers. |
|
| The Pretesting Company v. The Arbitron Company 93 Civ. 6031 (CBM) S.D.N.Y. Patent, unfair competition and false advertising action concerning automated television audience survey system. |
|
| Wesley-Jessen Corporation v. Ciba Vision Corporation Civil Action No. 90-SLR (SLR), D. Del. Patent and antitrust action concerning color contact lenses. |
|
| Baxter Healthcare Corporation et al. v. Acufex Microsurgical, Inc. Civil Action No. 88-408 JSL (RWRx), N.D. Cal./D. Mass. Patent action concerning arthroscopic surgical equipment. |
|
| In re Nifedipine Capsule Patent Litigation MDL 774 M21-51 (JFK), Multi-district. Multiple actions concerning the cardiovascular drug Procardia® against generic drug manufacturers under Hatch-Waxman Act. |
|
| American Cyanamid Co. v. Ethicon, Inc. Civil Action No. 85-3053 (JCL), D.N.J. Action under 35 USC § 146 concerning priority of surgical suture invention. |
|
| Procter & Gamble Co. v. Nabisco Brands, Inc. et al. Civ. Action No. 84-333 LON, D. Del. 697 F. Supp. 1360 (D. Del. 1988). The "Cookie Wars": Wall Street Journal, Sept. 11,1989 U.S. News & World Report, Sept. 25, 1989. Large-scale trade secret misappropriation, industrial espionage, patent and unfair competition suit. |
|
| Foreign Exchange and Investment Ltd. v. Ideal Consolidators Civ. Nos. 91-2334 (MTB); 91-2335 (AJL) D.N.J. |
|
| United States v. Marine Shale Processors Environmental case. |
|
| Sky Chefs, Inc. v. Delaware North Companies Inc. Leveraged-buyout case. |
|
| Transactions: | |
| Indian Pharmaceutical Companies Asset sales and stock transactions. |
|
| Bentley Pharmaceuticals Public Offerring |
|
| Ziff-Davis Interchange®/Private Bidder Bid for MultiMedia software business. |
|
| Eastman Kodak Company/Sterling Drug Co. Bids to purchase diagnostic business. |
|
| Sivensa S.A./FIOR Representation of Venezuelan industrial company in various trade secret, trademark, technology transfer and patent matters. |
|
| Engelhard Inc./Degussa Corporation and Degussa AG. Propoed sale and licnesing of world-wide precious metals businesses. |
|
| Negotiations concerning IBM hardware and software licenses relating to personal computer technology. | |
